Inventor · disambiguated record
Bin Ma
Also filed as: MA BIN
37 granted patents·9 pending applications·143 citations·filing 2009–2025
97Inventor score
Top patents by PatentIndex Score
46 records- 0193US11427577B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2021·Granted Aug 30, 2022·2 cites·9 claims
- 0292US10961237B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2019·Granted Mar 30, 2021·4 cites·6 claims
- 0392US10166250B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Jan 1, 2019·9 cites·11 claims
- 0492US9572824B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Feb 21, 2017·10 cites·14 claims
- 0592US8802659B2Bicyclic aryl sphingosine 1-phosphate analogsTHOMAS JERMAINE·Filed 2010·Granted Aug 12, 2014·20 cites·24 claims
- 0691US10081619B2Biaryl inhibitors of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·7 cites·4 claims
- 0791US9827258B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Nov 28, 2017·8 cites·10 claims
- 0891US9809577B2Biaryl inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2014·Granted Nov 7, 2017·12 cites·2 claims
- 0990US10759783B2Biaryl inhibitors of Bruton'S tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Sep 1, 2020·3 cites·11 claims
- 1090US10227341B2Inhibiting agents for bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Mar 12, 2019·8 cites·26 claims
- 1189US10189829B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Jan 29, 2019·6 cites·8 claims
- 1286US9550798B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Jan 24, 2017·8 cites·25 claims
- 1385US9555050B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Jan 31, 2017·4 cites·24 claims
- 1484US9850206B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 26, 2017·4 cites·22 claims
- 1584US9340527B2S1P modulating agentsTHOMAS JERMAINE·Filed 2012·Granted May 17, 2016·6 cites·38 claims
- 1684US9181191B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2012·Granted Nov 10, 2015·3 cites·38 claims
- 1782US11858926B2Inhibiting agents for bruton's tyrosine kinaseBIOGEN MA INC·Filed 2022·Granted Jan 2, 2024·0 cites·5 claims
- 1882US9522889B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 20, 2016·5 cites·31 claims
- 1982US8349849B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2009·Granted Jan 8, 2013·6 cites·21 claims
- 2081US10034869B2S1P modulating agentsBIOGEN MA INC·Filed 2017·Granted Jul 31, 2018·2 cites·18 claims
- 2180US12391697B2Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Aug 19, 2025·1 cites·20 claims
- 2280US9808449B2S1P modulating agentsBIOGEN MA INC·Filed 2015·Granted Nov 7, 2017·2 cites·21 claims
- 2379US9499485B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Nov 22, 2016·4 cites·14 claims
- 2477US8546359B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2012·Granted Oct 1, 2013·4 cites·31 claims
- 2576US10894040B2S1P modulating agentsBIOGEN MA INC·Filed 2019·Granted Jan 19, 2021·0 cites·20 claims
- 2674US8269043B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2009·Granted Sep 18, 2012·2 cites·19 claims
- 2773US10899753B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2019·Granted Jan 26, 2021·1 cites·20 claims
- 2868US11572356B2Biaryl inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Feb 7, 2023·0 cites·17 claims
- 2968US9765016B2S1P modulating agentsBIOGEN MA INC·Filed 2014·Granted Sep 19, 2017·1 cites·18 claims
- 3066US10280169B2Biaryl bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2014·Granted May 7, 2019·1 cites·16 claims
- 3166US2019209592A1Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 3265US10406144B2SIP modulating agentsBIOGEN MA INC·Filed 2018·Granted Sep 10, 2019·0 cites·18 claims
- 3361US2022048884A1Nrf2 activatorBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 3460US10081646B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·0 cites·26 claims
- 3557US2025034150A1Btk inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 3657US2025090524A1Btk inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 3755US9708353B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Jul 18, 2017·0 cites·29 claims
- 3852US2019389836A1Nrf2 activatorBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 3952US2024083900A1Pyrazolo[1,5-a]pyrazine derivatives as btk inhibitorsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 4052US2024327380A1Btk inhibitorsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 4149US12240838B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Mar 4, 2025·0 cites·21 claims
- 4248US9944666B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2016·Granted Apr 17, 2018·0 cites·15 claims
- 4347US10017506B2ATX modulating agentsBIOGEN MA INC·Filed 2016·Granted Jul 10, 2018·0 cites·21 claims
- 4445US10273234B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Apr 30, 2019·0 cites·14 claims
- 4545US2025313563A1Glycogen synthase kinase 3 inhibitors and uses thereofBROAD INST INC·Filed 2025·Application pending·0 cites
- 4636US2010240617A1Bicyclic sphingosine 1-phosphate analogsUNIV VIRGINIA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bin Ma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →